Back

Right atrial substrate ablation for persistent atrial fibrillation is associated with higher atrial tachycardia recurrence: proarrhythmic effect or distinct substrate?

12 April 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: Poster session (1): supraventricular arrhythmias Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Rita-Beata Gagyi

University of Szeged, Szeged (Hungary)

196 More presentations in this session

Presentation thumbnail
Electrocardiographic differentiation of narrow QRS complex tachycardia: validation of the new aVL and aVR criteria and a unifying approach to ECG analysis
Doctor J. Stec (Cracow, PL)
Abstract Slides Video
Presentation thumbnail
Characterization of paroxysmal atrial fibrillation in atrial septal defects: contribution of a left atrial substrate
Doctor N. Ramdat Misier (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Spatial distribution of effective refractory period in atrial fibrillation patients
Associate Professor A. Loewe (Karlsruhe, DE)
Abstract Slides
Presentation thumbnail
Early onset atrial fibrillation as a marker of inherited cardiomyopathy: lessons from combined imaging and genetic assessment
Doctor V. Rella (Milan, IT)
Abstract Slides Video
Presentation thumbnail
BMI discrepancy and new-onset atrial fibrillation: findings from UK biobank
Doctor J. Choi (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session (1): supraventricular arrhythmias

The Event

Event poster

EHRA 2026

12 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Science: persistent atrial fibrillation ablation
thumbnail
Congress Presentation
Strategies for recurrent atrial fibrillation in patients despite durable pulmonary vein isolation
thumbnail
Congress Presentation
First-time catheter ablation outcomes for atrial fibrillation are dependent on low-voltage areas rather than paroxysmal vs. persistent classifications: a REAL-AF study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources